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Abstract
Clinical, Pulmonary function and blood gas studies carricd out in 129 symptomatic toxic gas exposed
individuals 1-3 months after exposure had revealed that pulmonary function measurements such as
FVC, FEV1 and FMF 25-75% were significantly lower in toxic gas exposed subjects and 57 subjects
(44.2%) had ventilatory impairment.The predominant type of ventilatory defect was combined
obstruction and restriction.Of these 57 subjects, 5 (9%) had severe respiratory impairment. With
increasing severity of exposure, there was a tendency for a higher proportion of subjects to have
increasing impairment in pulmonary function and this trend was significant statistically (P<0.001).
Isolated small airway disease was present in 9 (7%) subjects.20.3% of patients with normal physical
findings and 19.1% with normal chest roentgenograms had abnormal pulmonary junction.Arte ial
hypoxemia and ventilatory abnormalities were predominant in severely exposed patients.Further
studies are required to identify the subgroup o/patients with Reactive Airways Dysfunction Syndrome.
Long term follow-up is essential to categorise the pulmonary syndromes due to toxic gas exposure.
Introduction
The leakage of toxic gas from the Union
Carbide Factory at Bhopal on the night of 2-3
December, 1984 had resulted in the death of
nearly 2500 people and morbidity in nearly
200000 people. The main organ involved was
the lung and the patients were complaining of
respiratory symptoms 1 to 3 months after
exposure to the poisonous gas. The short term
and long term effects of the toxic gas on human
systems are not currently known and hence the
Indian Council of Medical Research undertook
this preliminary study to understand the effects
of toxic gas on Respiratory system. This study
was done during January - March, 1985.
Materials and Methods
Study Population
One hundred and fifty three patients
exposed to toxic gas and presenting with
respiratory symptoms were studied at the MIC
clinic at Hamidia Hospital, Bhopal.Four
  categories of patients were observed at the time
of initial screening. They were as follows:
a. Patients with respiratory symptoms such
as dyspnoea at rest who required immediate
hospitalisation. Pulmonary function tests could
not be done in these patients because of their
symptoms.
b. Patients exposed to toxic gas, not
acutely ill, but presenting with respiratory
symptoms such as cough and breathlessness on
exertion. These patients did not have any
apparent pre-existing cardio-respiratory
disease prior to exposure. Pulmonary function
tests were carried out in all these patients.
c. Patients with pre-existing
cardio-respiratory diseases such as pulmonary
tuberculosis,chronic bronchitis, bronchial
asthma, bonchiectasis etc.Pulmonary
functions were carried in thirteen of this
category and numbers were not sufficient for
reporting.
d. Patients exposed to toxic gas, but do not
have any respiratory symptoms. Only a very
few patients of this category attended the
hospital for pulmonary function testing.
Pulmonary functions were mainlyc rried
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out in category b patients and this paper dealsa Severe Exposure:
with pulmonary function abnormalities in these
patients. If one of the members of the family died
due to toxic gas exposure or the patient became
Clinical assessment and investigations ofunconscious after exposure or the patient had
each patient included detailed history, physicalsevere ophthalmic symptoms along with severe
examination and a full palte PA chest X-ray respiratory symptoms requiring immediate
examination. Patients with pre-existing medical help with somebody’s help, the patient




After exposure to toxic gas, if the patient
The pulmonary function tests were donedeveloped respiratory symptoms and required
on the vitalograph. The tests were carried outimmediate medical relief, the patient was
in the sitting posture and a minimum of twoclassified as having moderate exposure.
consistent readings were obtained. All the
values were expressed in BTPS and highest 
value obtained was used for analysis.The
c. Mild Exposure:
following pulmonary functions were carried
out.
i.Forced Vital Capacity (FVC)
ii.Forced Expiratory Volume in 1 Sec (FEV1)
iii.FEV1/FVC %
iv.Forced Mid-Expiratory Flow 22-75%
(FMF25-75%)
v.Spirometric response to inhaled
bronchodilators: 31 patients. who had
obstructive or obstructive cum restrictive
ventilatory defect were given two ‘puffs’ of
salbutamol from a inhaler and the spirometry
was repeated 15 minutes later. The changes in
FEV1 and FVC were recorded and the sum of
the percentage changes in FEV1 and FVC was
calculated. The results were reported as no




After exposure to toxic gas, if the patient
developed respiratory symptoms and the
patient did not seek immediate medical relief
because of mild symptoms, the patient was
classified as having mild exposure.
Classification of pulmonary function
abnormalities:
As there were no facilities for measuring
lung volumes and diffusion, classification of
pulmonary function abnormalities into
restrictive and combined obstructive cum
re trictive types was difficult. However, the
basis for classification of ventilatory defect into
3 types i.e obstructive, restrictive and combined
obstructive and restrictive types (Miller et al
1956), using the predicted normal values of
pulmonary function (Jain and Ramiah 1967 and
1969) was as follows:
Arterial blood gas analysis (pH, PO2 and
P C O2) were done in 35 cases using thea. Obstructive ntilatory defect:
InstrumentationLaboratory Blood Gas
Analyser. The arterial puncture was done inWhen the ratio of measured FEV1 to
the lying down position with the patient measured FVC was less than 75% and the ratio
breathing atmospheric air. of measured FVC to predicated FVC was more
than 75%, the patient was classified as having
Classification of severity of exposure
obstructive ventilatory defect.
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b. Restrictive ventilatory defect:
When the ratio of measured FVC to
predicted FVC was less than 75% and the ratio
of measured FEV1 to measured FVC was more
than 75%, the patient was classified as having
restrictive ventilatory defect.
c. Obstructive cum Restrictive ventilatory
defect:
When the ratio of measured FEV1 to
measured FVC was less than 75% and also the
ratio of measured FVC to predicted FVC was
less than 75%, the patient was classified as
having combined obstructive cum restrictive
ventilatory defect.
The respiratory impairment was
categorised by pulmonary function testing as
follows (ATS, 1986):
a.Mildly impaired: FVC 60% to 79% of
predicted or FEV1 60% to 79% of predicted,
or FEV1/FVC x100 60% to 74%.
b.Moderately impaired: FVC 51% to 59%
of predicted or FEV1 41% to 59% of predicted
of FEV1/FVC x100 41% to 59%.
c.Severely impaired: FVC 50% or less of
predicted or FEV1 40% or less of predicted or
FEV1/FVC x100 40% or less.
In the presence of normal values of FVC,
FEV1 and FEV1/FVC x100, a reduction in
Forced Mid-Expiratory Flow 25-75% (FMF
25-75%) less than 75% of predicted is
considered as evidence of small airway disease
(McFadden et al 1972).
Analysis
Twenty four patients were excluded from
analysis due to various reasons viz., old
pulmonary tuberculosis (3), bronchial asthma
and allergic rhinitis (2), chronic bronchitis (5),
cyst in the lung (1), exposure to hydrochloric
acid (1), Bronchiectasis (1), insufficient
information (9) and normal subjects (2).
Data are presented as mean ± SD. Data
were analysed by the students t tests. The trend
chi square test was applied to see whether the
level of exposure had any trend effect on
pulmonary function.
Results
There were 90 males and 39 females in the
study. The mean age of the males was 3 4
± 11.5 years (range 12-70 years) and of females
30.9 ± 10.3 years (range 12-55 years), the mean
height 1.65 ± 0.07 meters (males) and 1.54±
0.005 meters (females) and the mean weight
52.1 ± 12.0 Kg (males) and 46.0 ± 12.2 Kg
(females). There were 14 patients with mild
exposure, 49 with moderate exposure, and 66
with severe exposure. 32 males were smokers,
17 of them were smoking less than 5 cigarettes
or bidis (sun cured tobacco packed 1oosely
inside vegetable leaves) a day. Only five were
smoking more than 10 cigarettes or bidis per
day. Since there was no significant difference in
pulmonary functionbetween smokers and
non-smokers, data were pooled for analysis.
Fifty three patients (41.1%) were from low
socio-economic status (less than 500 rupees a
month), 42 (32.5%) middle (500-1500 rupees)
and 34 (26.4%) high (more than 1500 rupees).
All patients in this study were residents of areas
within 2 kilometers of Union Carbide factory
and most lived within 1 kilometer. There were
21 patients (16%) with dusty occupation such
as labourers, painters, carpenters, masons,
tailors, truck drivers etc and 81 (62.8%) were
engaged in non-dusty occupations
(Government employees, Engineers, Doctors,
Business Executives, students etc). Twenty four
females were house wifes and three did not
have any occupation.
Clinical and X-ray findings:
Majority of the patients complained of
breathlessness on exertion, 105 (81%) and
cough, 95 (74%). A few, 42 (33%) had chest
pain. The cough was not associatead with
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expectoration. Usually cough was associated
with breathlessness. A remarkable feature of
the symptomatology was the absence of fever.
  Symptoms of the patients are given in Table 1.
Auscultatory findings were normal in 79 (61%)
patients. The abnormalities noticed on
auscultation were rales in 27 (21%) patients,
rhonchi in 8 (6%) and rhonchi and rales in 15
(12%). Fifty six (43%) patients had increased
bronchovascular markings on X-ray chest. A
substantial number of patients, 47(36%) had
normal chest X-rays.Other abnormalities
noticed in X-ray chest were reticular shadows
in 22 patients (17%), pleural involvement in 3
(2%), raised diaphragm in 2 (15%) and
cardiomegaly in one.All X-rays, were taken
one month after the exposure of gas and hence
none had X-rayfindings suggestive of
pulmonary oedema.
Pulmonary function:
Pulmonary function results are shown in
Tables 2 and 3. Pulmonary function
measurements such as FVC, FEV1 and FMF
25-75% were significantly lower in both males
and females compared to the predicted normal
values.
Pure obstructive ventilatory defect was
observed in 13 patients (10.1%), restrictive
defect in 16 (12.4%) and obstructive cum
restrictive defect in 28 (21.7%).
T able 2: Pulmonary Function Results
Figure.5 in Parenthesis are percentages
72 patients  (55.8%) had normal
ventilatory function. Thus a total of 57 patients
(44.2%) had abnormal pulmonary function as a
result of exposure to toxic gas.Of the 57
patients with ventilatory impairment, 20 (35%)
had mild, 32 (56%) moderate and 5 (9%)
severe impairment. Of the 72 patients with
normal pulmonary function, 9 had isolated
small airway disease as evidenced by lone
reduction in FEF 25-75% and only one was a
smoker. Thus 9 patients out of 129 (7%) had
isolated small airway disease following toxic gas
exposure.
Severitiy of exposure Vs pulmonary function:
Forty three of 66 patients (65.2%) with
severe exposure had ventilatory defect whereas
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none of the mildly exposed patients had
ventilatory defect (Table 4). With increasing
severity of exposure, there was a tendency for a
  higher proportion of patients to have increasing
pulmonary function impairment and this trend
was significant statistically (P < 0.001).
with increased bronchovascular markings had
abnormal pulmonary function.This may be
due to the subjective nature of this category.
On the other hand, 77.3% (17 of 22) of patients
with reticular shadows and all patients with
pleural involvement had abnormal pulmonary
function. In two patients with raised
diaphragm, one had restrictive abnormality and
the other had normal pulmonary function, but
was associated with hypoxemia.Nine of 47
patients (19.1) with normal chest x rays had
abnormal pulmonary function (Table 6).
Trend chi square test, p < 0.001.
Physical findings Vs pulmonary function:
It was observed that abnormal physical
f indings w e r e associated with abnormal
pulmonary function in 82% (41 of 50) of cases.
It can further be observed that in 20.3% (16 of
79) cases with normal physical findings had
abnormal pulmonary function (Table 5).
X-ray findings Vs Pulmonary Function:
Though increased bronchovascular
markings were the predominant chest x ray
abnormalitiy, only 51.8% (29 of 56) of patients
Table 6: X-ray findings Vs Pulmonary function.
percentages.
Response to Bronchodialators:
None of the patients (n:31) assessed had
any previous episodes of bronchial asthma.
However, one patient had a history of atopy
and another had a family history of bronchial
asthma. 13 (41%) out of 31 patients had shown
reversibility to bronchodialators and 9 (29%)
had marked reversibility suggesting the
possibility of Reactive Airways Dysfunction
Syndrome (Brooks et al, 1985).
Blood gas results:
Arterial oxygen tensions were done in 35
patients. Severe hypoxemia (<60 mm Hg) was
observed in 3 patients (9%) and two of these
subjects could not perform pulmonary function.
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Moderate (61-70 mm Hg) hypoxemia was
present in 7 cases (20%) and mild (71-85 mm
 Hg) in 14 cases (40%).
F
23 of 29 (793%) severely exposed
patients had hypoxemia. All 3 patients who
had PO2 of less than 60 mm Hg had severe
exposure. Only one patient with moderate
exposure had hypoxemia. All other moderately
exposed (n:4) and mildly exposed (ml) patients
had normal PO2 (Table 7). All patients (n:10)
with combined obstruction and restriction had
hypoxemia (Table 8). 7 patients (21%) with
hypoxemia had normal pulmonary function.
Hypocapnia (i.e. arterial CO2 tension less than
 35 mm Hg) was observed in 12 cases (34%).
None had hypercapnia (i.e. CO2 tension more
than 46 mm Hg).
Pulmonary function tests carried out 1-3
months after exposure to toxic gas had revealed
that there was significant reduction in
pulmonary function in individuals attending the
hospital with respiratory symptoms and 44.2%
of them had ventilatory impairment.The
predominant type of ventilatory defect was
combined obstruction and restriction. Majority
of patients with abnormal physical findings had
abnormal pulmonary function.Abnormal
pulmonary function were noticed mainly in
severely and moderately exposed patients, and
all patients who had mild exposure had normal
pulmonary function. However, the
observations that 20.3% of patients with normal
physical findings and 19.1% of patients with
normal chest X-rays had abnormal pulmonary
function suggest that complete evaluation
including pulmonary function testing are  
essential in all patients, even if physical findings
and chest X-rays are normal. Arterial blood
gas analysis in 35 patients had shown that 3
patients were in respiratory failure (pO2 <60
mm Hg); and hypoxemia was observed mainly
in patients with severe exposure and with
severe pulmonary function impairment as
evidenced by combined obstruction and
restriction.
The absence of fever and the findings that
cough was associated with breathlessness and
not with expectoration suggest that the
respiratory symptoms in these patients may not
be due to bacterial or viral infections. This is
further supported by the absence of
radiographic evidence of pneumonia or
bronchopneumonia in these subjects. The fact
that only 16% of patients in this study were
engaged in dusty occupation and that only five
subjects were heavy smokers point to the
probability that the respiratory symptoms and
ventilator-y impairment in most of the patients
are not due to occupational/environmenta1
exposures or smoking. The development of
respiratory symptoms and the persistence of
ventilatory impairment in a substantial number
of subjects. following toxic gas exposure, and
the fact that these subjects had no pre-existing
lung disease prior to exposure and were
residing in the vicinity of Union Carbide factory
at the time of exposure suggest the possibility
that the respiratory morbidity in these subjects
might have resulted from inhalation of the toxic
gas.
Previously it had been reported that the
commonest lung function abnormality in toxic
gas exposed subjects was airflow limitation with
or without reduction in lung volume (Bhargawa
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et al 1987). However, Kamat et al (1987) found
a predominant restrictive lung disease betwe n
the seventh and 55th days after exposure. Two
months after xposure, Rastogi et al (Rastogi et
al 1988) observed that 39% of 783 patients had
ventilatory impairment, a finding similar to the
present study.
Eventhough 44.2% of patients attending
the hospital with symptoms had ventilatory
abnormalities, a thorough follow-up of these
patients at 1/2 yearly or yearly intervals will only
answer the question whether the ventilatory
abnormalities are reversible or not.Even
individuals with normal ventilatory function
should be followed up to observe any
progressive abnormalities developing on a long
term basis. Clinical and Pulmonary function
studies had shown that 2 types of clinical
syndromeswere induced by toxic gas
inhalation. The first was due to high-dose
exposure of toxic gas, resulting in pulmonary
oedema and high mortality immediately after
the exposure (Misra et al 1987). The second
syndrome was characterised by dyspnoea on
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abnormalities of obstruction and restriction in
subacute stage as demonstrated in our subjects.
This may lead to chronic lung disease. The
finding of reversibility to bronchodilators in a
substantial number of subjects without previous
history of bronchial asthma and atopy suggests
the possibility of a third syndrome resulting in
Reactive AirwaysDysfunction Syndrome
(Brooks et at 1985). Immunological
i vestigations coupled with pulmonary function
studies and bronchoalveolar lavage may help in
identifying the pulmonary syndromes caused by
toxic gas exposure.
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